34 results:
21. Administration  
AdministrationDosage recommendation Stroke Cerebrolysin belongs to agents used in post-stroke rehabilitation and it is recommended that its administration should be initiated as early as possible,…  
22. Administration  
ADMINISTRATIONDosage recommendation Dementia For the treatment of dementia one therapy course corresponds to a therapy duration of 4 weeks (5 applications/week). The effectiveness of therapy can…  
23. Adverse Events  
Dr. Barbara KDownload In case of emergencies please dial: Tel.: +43 7665 20 555 - 0  
24. Contact  
Contact EVER PharmaEVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria Phone: +43 7665 20555 0 Fax: +43 7665 20555 910 E-Mail: office(at)everpharma.com www.everpharma.com  
25. News  
News  
26. Administration  
ADMINISTRATIONDosage recommendation TBI Cerebrolysin should be administered as an adjunctive treatment to standard TBI care. The administration initiated optimally as soon as possible post-TBI and…  
27. Clinical Efficacy  
Clinical efficacy and patient benefits To date, more than 3000 patients have been included in clinical trials evaluating the efficacy of Cerebrolysin in Alzheimer's disease and vascular dementia.…  
28. Disease  
Disease Dementia is the loss of cognitive performance to such an extent that it interferes with a person In the treatment of dementia, early diagnosis is one of the key issues but the diagnosis…  
29. Trainings  
Video presentation about CARS studyCARS video Over the last decades, therapeutic approaches for stroke have significantly evolved. Implementation of modern stroke units, better general medical…  
30. Clinical Efficacy  
Clinical efficacy and patient benefits Treatment of stroke with Cerebrolysin helps to regain independence. Its efficacy has been proven in 36 double-blind-studies and trials with more than 5.000…  

Search results 21 until 30 of 34